Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuki Yajima
Observed names:
Yajima, Yuki,
Yuki YAJIMA
Institution:
Asahikawa Medical University
Observed institution:
Asahikawa Medical University
ORCID:
0000-0002-8454-7091
Observed ORCID:
0000-0002-8454-7091
OpenAlex ID:
A5085123339
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
2021
·
Akemi Kosaka
, Kei Ishibashi
, et al.
·
The Journal of Experimental Medicine
·
58
A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment
2021
·
Marino Nagata
, Akemi Kosaka
, et al.
·
Cancer Immunology Immunotherapy
·
32
Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma
2019
·
Shohei Harabuchi
, Akemi Kosaka
, et al.
·
Biochemical and Biophysical Research Communications
·
28
PDF
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer
2020
·
Mizuho Ohara
, Kenzo Ohara
, et al.
·
Cancer Immunology Immunotherapy
·
24
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
2020
·
Ryusuke Hayashi
, Toshihiro Nagato
, et al.
·
OncoImmunology
·
21
Celecoxib promotes the efficacy of STING ‐targeted therapy by increasing antitumor CD8 + T‐cell functions via modulating glucose metabolism of CD11b + Ly6G + cells
2022
·
Akemi Kosaka
, Yuki Yajima
, et al.
·
International Journal of Cancer
·
17
A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy
2021
·
Akemi Kosaka
, Yuki Yajima
, et al.
·
Cancer Science
·
12
PDF
A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity
2022
·
Yuki Yajima
, Akemi Kosaka
, et al.
·
Cancer Science
·
11
PDF
Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy
2023
·
Toshihiro Nagato
, Hiroki Komatsuda
, et al.
·
Cancer Immunology Immunotherapy
·
8
PDF
SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity
2023
·
Yuki Yajima
, Akemi Kosaka
, et al.
·
Heliyon
·
5
NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike protein
2024
·
Aiko Murai
, Terufumi Kubo
, et al.
·
Immunological Medicine
·
1
A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity
2022
·
Yajima, Yuki
·
Institutional Repositories DataBase (IRDB)
PDF
A case of angiosarcoma of the tongue
2022
·
Saori ARAI
, Yuki YAJIMA
, et al.
·
Japanese Journal of Oral & Maxillofacial Surgery
PDF
A case of maxillary vascular embolism caused by calcium hydroxide formulation
2020
·
Yuki YAJIMA
, Masaki FUJIMORI
, et al.
·
Japanese Journal of Oral & Maxillofacial Surgery
PDF
Show more works
View as search
Works count:
15
Citation count:
217
H-index:
8
I10-index:
8
Year
Topic
Type
